Carcinoembryonic Antigen-Related Cell Adhesion Molecule Type 5 Receptor-Targeted Fluorescent Intraoperative Molecular Imaging Tracer for Lung Cancer: A Nonrandomized Controlled Trial.

Azari F, Meijer RPJ, Kennedy GT, Hanna A, Chang A, Nadeem B, Din A, Pèlegrin A, Framery B, Cailler F, Sullivan NT, Kucharczuk J, Martin LW, Vahrmeijer AL, Singhal S

Open source

DOI
10.1001/jamanetworkopen.2022.52885
Published
2023 Jan 3
Container
JAMA network open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jamanetworkopen.2022.52885,
  title = {Carcinoembryonic Antigen-Related Cell Adhesion Molecule Type 5 Receptor-Targeted Fluorescent Intraoperative Molecular Imaging Tracer for Lung Cancer: A Nonrandomized Controlled Trial.},
  author = {Azari F and Meijer RPJ and Kennedy GT and Hanna A and Chang A and Nadeem B and Din A and Pèlegrin A and Framery B and Cailler F and Sullivan NT and Kucharczuk J and Martin LW and Vahrmeijer AL and Singhal S},
  year = {2023},
  journal = {JAMA network open},
  doi = {10.1001/jamanetworkopen.2022.52885},
  url = {https://doi.org/10.1001/jamanetworkopen.2022.52885}
}

RIS

TY  - JOUR
TI  - Carcinoembryonic Antigen-Related Cell Adhesion Molecule Type 5 Receptor-Targeted Fluorescent Intraoperative Molecular Imaging Tracer for Lung Cancer: A Nonrandomized Controlled Trial.
AU  - Azari F
AU  - Meijer RPJ
AU  - Kennedy GT
AU  - Hanna A
AU  - Chang A
AU  - Nadeem B
AU  - Din A
AU  - Pèlegrin A
AU  - Framery B
AU  - Cailler F
AU  - Sullivan NT
AU  - Kucharczuk J
AU  - Martin LW
AU  - Vahrmeijer AL
AU  - Singhal S
PY  - 2023
JO  - JAMA network open
DO  - 10.1001/jamanetworkopen.2022.52885
UR  - https://doi.org/10.1001/jamanetworkopen.2022.52885
ER  - 

APA

F, A., RPJ, M., GT, K., A, H., A, C., B, N., A, D., A, P., B, F., F, C., NT, S., J, K., LW, M., AL, V., & S, S. (2023). Carcinoembryonic Antigen-Related Cell Adhesion Molecule Type 5 Receptor-Targeted Fluorescent Intraoperative Molecular Imaging Tracer for Lung Cancer: A Nonrandomized Controlled Trial.. JAMA network open. https://doi.org/10.1001/jamanetworkopen.2022.52885

Source records